Jiri S.
- Country
- Czechia
- Department
- Klinika detskeho lekarstvi
Research Overview
- A Multicenter Randomized Non‑Inferiority Trial of Weekly Somatrogon versus Daily Somatropin in Pediatric Patients with Small‑for‑Gestational‑Age or Idiopathic Short Stature
- A 52-week randomized, double-blind, placebo-controlled, multi-center Phase 2b study with a 52-week blinded extension and an optional open-label extension—assessing the safety and efficacy of frexalimab, a CD40L-antagonist monoclonal antibody, for the preservation of pancreatic β-cell function in adults and adolescents with newly diagnosed type 1 diabetes on insulin therapy
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Combination with Metformin and/or Basal Insulin in Pediatric Type 2 Diabetes Patients
Data & Insights
Has run more than one trial at 5 of 87 partner sites.
Specializations
Diabetes Research
The investigator specializes in the management of both Type 1 and Type 2 diabetes, with particular emphasis on pediatric and adolescent populations. Their research interests focus on innovative therapeutic approaches for diabetes treatment in young patients.
- Adolescent Type 1 Diabetes Management
- Pediatric Type 2 Diabetes Treatment
- Endogenous Insulin Preservation
Their work extends to studying novel therapeutic agents for preserving natural insulin production in newly diagnosed patients.
Pediatric Medicine
The investigator demonstrates expertise in pediatric endocrinology, specifically focusing on metabolic disorders in children and teenagers aged 10-21 years. Their research encompasses comprehensive treatment approaches for young patients.
- Youth Metabolic Disorders
- Adolescent Medicine
- Pediatric Drug Development
Their work involves evaluating therapeutic interventions specifically designed for younger populations with metabolic conditions.
Therapeutic Innovation
The investigator focuses on novel therapeutic approaches in diabetes care, including the evaluation of new oral medications and targeted treatments for maintaining insulin production. Their research includes assessment of combination therapy approaches.
- Novel Drug Development
- Standard of Care Enhancement
- Therapeutic Drug Evaluation
Their expertise extends to investigating emerging treatments in conjunction with established therapeutic protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.